Literature DB >> 16706828

Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma.

Hiroki Uchida1, Yukio Iwashita, Atsushi Sasaki, Kohei Shibata, Toshifumi Matsumoto, Masayuki Ohta, Seigo Kitano.   

Abstract

BACKGROUND AND AIMS: Chemokines and their receptors have recently been shown to have major roles in cancer metastasis. The aim of this study was to determine whether the interaction between chemokine receptor 6 (CCR6) and its ligand, macrophage inflammatory protein-3 alpha (MIP-3alpha), correlates with metastasis of hepatocellular carcinoma (HCC).
METHODS: To observe the reaction of CCR6 expressed cancer cells to MIP-3alpha stimulation, chemotactic and actin polymerization assays for both CCR6 high cells (HepG2) and CCR6 low cells (MCF-7) were performed. CCR6 mRNA levels in tumor specimens from 30 HCC patients were quantified by real-time polymerase chain reaction. Patients were classified into two groups, high (>or= 20 copies; n=10) CCR6 and low (<20 copies; n=20) CCR6 on the basis of CCR6 expression, and the groups were compared with respect to clinicopathological features.
RESULTS: When HepG2 cells (CCR6 high) were stimulated with MIP-3alpha, they migrated in a dose-dependent manner, and formation of pseudopodia was observed. These phenomena were not observed in the CCR6 low cells. The incidence of intrahepatic metastasis was higher in the high CCR6 expression group than in the low CCR6 expression group (P<0.05). Disease-free survival was significantly poorer in the high CCR6 expression group than in the low CCR6 expression group (P<0.05).
CONCLUSIONS: It was indicated that CCR6 might be associated with intrahepatic metastasis of HCC and might be able to become one of the prognostic factor after hepatic resection for HCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706828     DOI: 10.1111/j.1440-1746.2005.04157.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  18 in total

1.  Expression of the chemokine receptor CCR6 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.

Authors:  Yoshihiro Minamiya; Hajime Saito; Naoko Takahashi; Manabu Ito; Hiroshi Toda; Takashi Ono; Hayato Konno; Satoru Motoyama; Jun-Ichi Ogawa
Journal:  Tumour Biol       Date:  2010-09-25

Review 2.  Chemokines and their receptors play important roles in the development of hepatocellular carcinoma.

Authors:  Chun-Min Liang; Long Chen; Heng Hu; Hui-Ying Ma; Ling-Ling Gao; Jie Qin; Cui-Ping Zhong
Journal:  World J Hepatol       Date:  2015-06-08

Review 3.  Chemokines and hepatocellular carcinoma.

Authors:  Fan Huang; Xiao-Ping Geng
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

4.  The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis.

Authors:  Xiaolei Jiao; Guiming Shu; Hui Liu; Qin Zhang; Zhe Ma; Chaoyi Ren; Hongsheng Guo; Jingxiang Shi; Junguo Liu; Chuanshan Zhang; Yijun Wang; Yingtang Gao
Journal:  J Histochem Cytochem       Date:  2019-01-11       Impact factor: 2.479

5.  The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.

Authors:  Tong Li; Hui Li; Yucheng Wang; Chansonette Harvard; Jia-Li Tan; Alfred Au; Zhidong Xu; David M Jablons; Liang You
Journal:  J Pathol       Date:  2011-01-05       Impact factor: 7.996

6.  Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.

Authors:  Claudia Rubie; Vilma Oliveira Frick; Mathias Wagner; Christina Weber; Bianca Kruse; Katja Kempf; Jochen König; Bettina Rau; Martin Schilling
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

Review 7.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

8.  Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.

Authors:  Liang Wang; Huaizhou Qin; Lihong Li; Yongsheng Zhang; Yanyang Tu; Fuqiang Feng; Peigang Ji; Jingyu Zhang; Gang Li; Zhenwei Zhao; Guodong Gao
Journal:  Med Oncol       Date:  2012-08-28       Impact factor: 3.064

Review 9.  G-protein coupled chemoattractant receptors and cancer.

Authors:  Jian Huang; Keqiang Chen; Wanghua Gong; Nancy M Dunlop; Ji Ming Wang
Journal:  Front Biosci       Date:  2008-05-01

10.  Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer.

Authors:  Pirus Ghadjar; Christoph Loddenkemper; Sarah Ellen Coupland; Andrea Stroux; Michel Noutsias; Eckhard Thiel; Frank Christoph; Kurt Miller; Carmen Scheibenbogen; Ulrich Keilholz
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-09       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.